Mediclinic International plc
MEI
Peringkat dalam Saham
#4308
Mediclinic International plc is a prominent healthcare provider that, through... Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Harga Saham
$6.02
Terakhir disinkronkan: 2023-05-26
Kapitalisasi Pasar
$3.60B
Perubahan (1 hari)
-18.50%
Perubahan (1 tahun)
0.00%
Negara
ZA
Perdagangan Mediclinic International plc (MEI)
Kategori
Healthcare
Rasio P/E untuk Mediclinic International plc (MEI)
Rasio P/E per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Mediclinic International plc, rasio P/E saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki rasio P/E sebesar 0.
Riwayat rasio P/E untuk Mediclinic International plc dari 2002 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2022 | 17.56 | -43.29% |
| 2021 | 30.96 | -586.55% |
| 2020 | -6.36 | -64.10% |
| 2019 | -17.72 | 89.04% |
| 2018 | -9.38 | -141.09% |
| 2017 | 22.82 | -24.64% |
| 2016 | 30.28 | -21.51% |
| 2015 | 38.58 | -18.27% |
| 2014 | 47.21 | -124.04% |
| 2013 | -196.35 | -336.10% |
| 2012 | 83.17 | -3.97% |
| 2011 | 86.61 | -7.45% |
| 2010 | 93.58 | -39.01% |
| 2009 | 153.45 | 33.63% |
| 2008 | 114.83 | 13.18% |
| 2007 | 101.46 | -35.50% |
| 2006 | 157.31 | 40.75% |
| 2005 | 111.77 | 37.29% |
| 2004 | 81.41 | -27.27% |
| 2003 | 111.93 | -35.11% |
| 2002 | 172.49 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 15.70 | - |
US
|
|
| - | - |
DE
|
|
| 10.40 | - |
US
|
|
| 30.12 | - |
SA
|
|
| 20.00 | - |
BR
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.